Product Code: GVR-4-68039-989-1
Forensic Genomics Market Growth & Trends:
The global forensic genomics market size is expected to reach USD 1.32 billion by 2030, registering a CAGR of 14.92% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is owing to a significant increase in violent crimes, globally. Murder, intentional homicide, robbery, etc. are the key factors driving the growth of the industry. The Federal Bureau of Investigation predicted that there will be 1.31 million violent crimes in 2021. Homicides accounted for approximately 40.00% since before the pandemic, according to the FBI's estimated homicide data. Forensic DNA profiling allows the identification of individuals of those who are already known to the investigating authorities.
New genetic markers have been produced as a result of recent research and they have the potential to address some significant shortcomings in DNA profiling techniques. In addition, several developments allow new kinds of relevant information to be obtained from biological samples. These include new molecular techniques for locating individuals that investigators were previously unaware of, and novel molecular approaches to support connections between criminal acts and sample donors. Such advancements in genomics, genetics and molecular biology are expected to enhance human forensic casework in the coming years. Advancements in technology have helped scientists create DNA fingerprints with smaller samples of DNA, therefore a suspect can be identified from a small amount of blood sample.
Next-generation Sequencing (NGS) offers results quickly and at a lower cost than other conventional techniques. Accordingly, to improve DNA testing accuracy, the number of regions used in STR analysis increased from 13 to 20 in 2017. In February 2022, researchers from the University of Washington along with the U.S. Department of Homeland Security used DNA testing of ivory shipments confiscated by law enforcement to identify the global criminal groups involved in ivory smuggling out of Africa. The kits & consumables product segment captured the highest revenue share in 2024 due to the high public & private investments in the development of DNA forensics.
The consumables include centrifuge tubes, cotton swabs, and filter baskets among others. The capillary electrophoresis method segment dominated the industry in 2024. Capillary electrophoresis is a fully automated technique used for detecting and separating Short Tandem Repeat (STR) alleles in genomic laboratories. Criminal testing was the largest application segment in 2024 owing to the increasing use of molecular testing technology for criminal investigation. North America dominated the global industry in 2024 due to various technological developments in the forensic sciences and growing investigation consent for forensic processes, such as biometric analysis methods and DNA profiling.
Forensic Genomics Market Report Highlights:
- The growth of the overall market is attributed to the increasing crime rates along with the introduction of advanced technology for forensic testing
- In 2024, the kits & consumables segment dominated the market, accounting for 67.23% of total revenue, And the software segment is expected to grow at the highest CAGR from 2025 to 2030
- The capillary electrophoresis (CE) segment dominated the market in 2024 with a revenue share of 36.96% and The next-generation sequencing (NGS) segment is expected to experience the highest growth rate during the forecast period
- Key players are focusing on several strategic alliances, which, in turn, is driving the global industry
- The facility is equipped with advanced technologies, which would help researchers make evidence-based decisions
- The partnership would provide affordable whole genome sequencing services for complex samples and standardize bioinformatic techniques for FIGG analysis
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product Segment
- 1.2.2. Method Segment
- 1.2.3. Application Segment
- 1.3. Information Analysis
- 1.3.1. Market Formulation & Data Visualization
- 1.4. Data Validation & Publishing
- 1.5. Information Procurement
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.1.1. Rising Government Funds And Initiatives For Forensic Programs
- 3.3.1.2. Increasing Crime Rates
- 3.3.1.3. Technological Advancements In Paternity & Familial Testing
- 3.3.2. Market Restraint Analysis
- 3.3.2.1. High Cost Of Equipment
- 3.3.2.2. Lack Of Skilled Professionals In Developing Countries
- 3.4. Industry Analysis Tools
- 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
- 3.4.2. Porter's Five Forces Analysis
- 3.4.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
- 4.1. Product Segment Dashboard
- 4.2. Global Forensic Genomics Market: Product Movement Analysis
- 4.3. Global Forensic Genomics Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Analyzers & Sequencers
- 4.4.1. Analyzers & Sequencers Market, 2018 - 2030 (USD Million)
- 4.5. Software
- 4.5.1. Software Market, 2018 - 2030 (USD Million)
- 4.6. Kits & Consumables
- 4.6.1. Kits & Consumables Market, 2018 - 2030 (USD Million)
Chapter 5. Method Business Analysis
- 5.1. Method Segment Dashboard
- 5.2. Global Forensic Genomics Market: Method Movement Analysis
- 5.3. Global Forensic Genomics Market Size & Trend Analysis, by Method, 2018 to 2030 (USD Million)
- 5.4. Capillary Electrophoresis
- 5.4.1. Capillary Electrophoresis Market, 2018 - 2030 (USD Million)
- 5.5. Next-generation Sequencing
- 5.5.1. Next-generation Sequencing Market, 2018 - 2030 (USD Million)
- 5.6. PCR Amplification
- 5.6.1. PCR Amplification Market, 2018 - 2030 (USD Million)
- 5.7. Others
- 5.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
- 6.1. Application Segment Dashboard
- 6.2. Global Forensic Genomics Market: Application Movement Analysis
- 6.3. Global Forensic Genomics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 6.4. Criminal Testing
- 6.4.1. Criminal Testing Market, 2018 - 2030 (USD Million)
- 6.5. Paternity & Familial Testing
- 6.5.1. Paternity & Familial Testing Market, 2018 - 2030 (USD Million)
- 6.6. Others
- 6.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 7.3. North America
- 7.3.1. North America Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. U.S. Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Canada Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. Mexico Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.2. Germany
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Germany Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.3. UK
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. UK Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. France Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Italy Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Spain Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Denmark Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Competitive Scenario
- 7.4.8.3. Regulatory Framework
- 7.4.8.4. Sweden Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Competitive Scenario
- 7.4.9.3. Regulatory Framework
- 7.4.9.4. Norway Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Japan Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. China Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. India Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5.5. South Korea
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. South Korea Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5.6. Australia
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Australia Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Thailand Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Brazil Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Argentina Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.7. MEA
- 7.7.1. MEA Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. South Africa Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Saudi Arabia Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. UAE Forensic Genomics Market, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Kuwait Forensic Genomics Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participant Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2024
- 8.4. Participant's Overview
- 8.4.1. Illumina, Inc.
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Thermo Fisher Scientific, Inc.
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. Merck KGaA
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Agilent Technologies
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Promega Corporation
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. QIAGEN
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Bio-Rad Laboratories
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. LGC Limited
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. Tri Tech Forensics
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Verogen
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives